Homeopathic products should not be sold in Australian pharmacies because they place consumers at “unacceptable risk,” an independent review of pharmacy regulation for the Australian Department of Health has found.
In his interim report, review panel chairman Stephen King found homeopathy and homeopathic products should be kept out of pharmaceutical benefits scheme-approved pharmacies.
“The only defense put to the panel regarding homeopathy was that it was harmless and able to be used as a placebo in certain circumstances,” the report said. “The panel does not believe that this argument is sufficient to justify the continued sale of these products in pharmacies.”
Ian Carr, a pharmacist and member of Friends of Science in Medicine, welcomed the finding and said homeopathic products could be harmful if used in lieu of evidence-based treatments for serious conditions.
“My biggest complaint about the status of homeopathy is not that people are essentially putting placebos into their bodies, it’s that they are putting their trust in a certain way of thinking that has no evidence base,” he said.
“It means they’re not looking in the right places for information, which is concerning if they are suffering from serious health problems. Yes, there is always a small risk that scientifically proven medicines carry, but those medicines also offer a huge benefit. Homeopathy carries a small or medium risk with no benefit,” he said.
Homeopaths say that illness-causing substances can, in minute doses, treat people who are unwell and dilute these substances in water or alcohol.
They say the resulting mixture retains a “memory” of the original substance that triggers a healing response in the body.
These claims have been disproven by multiple studies.
In 2015 the Australian National Health and Medical Research Council reviewed 225 research papers on homeopathy and found there were “no health conditions for which there is reliable evidence that homeopathy is effective.”
“People who choose homeopathy may put their health at risk if they reject or delay treatments for which there is good evidence for safety and effectiveness,” it said.
An independent company reviewed the council’s analysis and appraised the evidence to prevent bias, drawing the same conclusions.
Carr said the interim report on pharmacy regulation was not tough enough on the wider complementary and alternative medicine sector.
In September last year the Australian government announced a more comprehensive system of post-market monitoring of products, which would provide the Therapeutic Goods Administration with better information about emerging safety issues.
Because of these and other changes under way, the panel had made no further recommendations on complementary and alternative medicine products (CAM), King said.
However, Carr said he would liked to have seen a more critical look at the sale of such products in pharmacies by the panel.
“I’m particularly concerned by pharmacies that place naturopaths in the pharmacy environment, given naturopaths promote treatments that are unscientific and unproven,” he said.
Professor of public health and medicines policy expert Ken Harvey agreed.
“There should be a completely separate section for CAM products and there should be a clear sign in that section that tells customers: ‘These products have not been evaluated by government to see if they work and they may interact with medications. Talk to a pharmacist,’” he said.
The report also found that community pharmacy expenditure and funding was “insufficiently transparent,” a concern given that community pharmacies draw funding from a range of federal, state and territory government programs.
Pharmaceutical Society of Australia (PSA) president Joe Demarte said the interim report had raised some concerning issues for the sector.
“We will consult with members from all areas of practice to comprehensively assess the interim report, which will inform PSA’s detailed response,” he said.
Republican US lawmakers on Friday criticized US President Joe Biden’s administration after sanctioned Chinese telecoms equipment giant Huawei unveiled a laptop this week powered by an Intel artificial intelligence (AI) chip. The US placed Huawei on a trade restriction list in 2019 for contravening Iran sanctions, part of a broader effort to hobble Beijing’s technological advances. Placement on the list means the company’s suppliers have to seek a special, difficult-to-obtain license before shipping to it. One such license, issued by then-US president Donald Trump’s administration, has allowed Intel to ship central processors to Huawei for use in laptops since 2020. China hardliners
A top Vietnamese property tycoon was on Thursday sentenced to death in one of the biggest corruption cases in history, with an estimated US$27 billion in damages. A panel of three hand-picked jurors and two judges rejected all defense arguments by Truong My Lan, chair of major developer Van Thinh Phat, who was found guilty of swindling cash from Saigon Commercial Bank (SCB) over a decade. “The defendant’s actions ... eroded people’s trust in the leadership of the [Communist] Party and state,” read the verdict at the trial in Ho Chi Minh City. After the five-week trial, 85 others were also sentenced on
‘DELUSIONAL’: Targeting the families of Hamas’ leaders would not push the group to change its position or to give up its demands for Palestinians, Ismail Haniyeh said Israeli aircraft on Wednesday killed three sons of Hamas’ top political leader in the Gaza Strip, striking high-stakes targets at a time when Israel is holding delicate ceasefire negotiations with the militant group. Hamas said four of the leader’s grandchildren were also killed. Ismail Haniyeh’s sons are among the highest-profile figures to be killed in the war so far. Israel said they were Hamas operatives, and Haniyeh accused Israel of acting in “the spirit of revenge and murder.” The deaths threatened to strain the internationally mediated ceasefire talks, which appeared to gain steam in recent days even as the sides remain far
RAMPAGE: A Palestinian man was left dead after dozens of Israeli settlers searching for a missing 14-year-old boy stormed a village in the Israeli-occupied West Bank US President Joe Biden on Friday said he expected Iran to attack Israel “sooner, rather than later” and warned Tehran not to proceed. Asked by reporters about his message to Iran, Biden simply said: “Don’t,” underscoring Washington’s commitment to defend Israel. “We are devoted to the defense of Israel. We will support Israel. We will help defend Israel and Iran will not succeed,” he said. Biden said he would not divulge secure information, but said his expectation was that an attack could come “sooner, rather than later.” Israel braced on Friday for an attack by Iran or its proxies as warnings grew of